Cancer metastasis inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/00 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2536288

It is intended to provide a cancer metastasis inhibitor, in particular, a drug which is useful in treating bone metastasis and liver metastasis. Namely, a cancer metastasis inhibitor comprising, as the active ingredient, a substance inhibiting the activities of insulin-like growth factor (IGF)-I and IGF-II. By using this inhibitor, cancer metastasis can be significantly inhibited.

L'invention vise à l'obtention d'un inhibiteur de métastase cancéreuse, en particulier un médicament utile pour traiter la métastase osseuse et la métastase hépatique. L'invention concerne, nommément, un inhibiteur de métastase cancéreuse comprenant, en tant que principe actif, une substance inhibant les activités du facteur de croissance insulinoïde 1 (IGF) et IGF-II. Par utilisation de cet inhibiteur, il est possible d'inhiber de manière significative la métastase cancéreuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cancer metastasis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer metastasis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer metastasis inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1818954

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.